PlainRecalls
FDA Devices Moderate Class II Terminated

Neoplastine¿ Cl Plus @ (ref.00374) Product Usage: Manual or automated determination of the prothrombin time (PT).

Reported: March 21, 2018 Initiated: October 25, 2017 #Z-1066-2018

Product Description

Neoplastine¿ Cl Plus @ (ref.00374) Product Usage: Manual or automated determination of the prothrombin time (PT).

Reason for Recall

Confirmed defect of homogeneity where some reagent vials will give prolonged Prothrombin Time (decreased PT%).

Details

Recalling Firm
Diagnostica Stago, Inc.
Units Affected
1636 Kits
Distribution
Nationally
Location
Parsippany, NJ

Frequently Asked Questions

What product was recalled?
Neoplastine¿ Cl Plus @ (ref.00374) Product Usage: Manual or automated determination of the prothrombin time (PT).. Recalled by Diagnostica Stago, Inc.. Units affected: 1636 Kits.
Why was this product recalled?
Confirmed defect of homogeneity where some reagent vials will give prolonged Prothrombin Time (decreased PT%).
Which agency issued this recall?
This recall was issued by the FDA Devices on March 21, 2018. Severity: Moderate. Recall number: Z-1066-2018.